Latest News
Luminex passes FDA EUA for NxTAG CoV extended panel to detect the SARS-CoV-2 under BARDA award
30 March 2020 - Clinical diagnostics company Luminex Corporation (NASDAQ:LMNX) revealed on Friday the receipt of Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for its high-throughput, scalable, cost-effective NxTAG CoV extended...
Abbott introduces fast molecular point-of-care test to detect COVID-19
30 March 2020 - Healthcare company Abbott (NYSE:ABT) reported on Friday the receipt of US Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for a fast molecular point-of-care test for the detection of novel coronavirus (COVID-19).A...
Ryvu Therapeutics wins FDA orphan drug designation for SEL120 to treat acute myeloid leukemia
30 March 2020 - Biopharmaceutical company Ryvu Therapeutics (WSE:RVU) reported on Saturday the receipt of US Food and Drug Administration (FDA) orphan drug designation (ODD) to advance SEL120 to address unmet medical needs in acute myeloid leukemia (...
Sterifre Medical seeks expedited approval of fast disinfectant system to reduce spread of COVID-19 across healthcare facilities
27 March 2020 - Medical technology company Sterifre Medical Inc said on Thursday that it has developed technology to help fight the spread of COVID-19 and other contagious pathogens.The AURA system enables fast and automated device disinfection at th...
Saniona announces collaboration agreement with Boehringer Ingelheim in schizophrenia
27 March 2020 - Saniona AB (STO:SANION), a clinical stage biopharmaceutical company focused on rare diseases of the central nervous system, announced on Thursday a new research collaboration with Boehringer Ingelheim in schizophrenia.Under this colla...